Prices / By channel
GLP-1 cost by channel
The same drug, every official way to pay for it, side by side. Checked Oct 17, 2026.
Short answer
For the same drug, the monthly cost depends on how you get it. Wegovy injection lists at $349–$399 a month at self-pay; with commercial insurance that covers it, Novo Nordisk's savings offer can bring it to as little as $25 a month; through Medicare's GLP-1 Bridge it is $50 a month if you qualify; with Medicaid it depends on your state.89102451112
Source: TrumpRx.gov, NovoCare, Medicare.gov, CMS and state Medicaid documents · checked Oct 17, 2026
| Product | Maker's self-pay price | Commercial insurance + maker savings offer | Medicare | Medicaid |
|---|---|---|---|---|
| Zepbound Single-dose vial · Eli Lilly | $299–$449 / fill*1 Some strengths cost more if a refill is more than 45 days late. | Not recorded yet Lilly's savings-card terms are entered by hand; not yet. Your plan's copay applies. | Not on the Bridge list2 Not one of the GLP-1 Bridge drugs. Check your own Part D plan. | |
| Zepbound KwikPen (multi-dose) · Eli Lilly | $299–$449 / fill*3 Some strengths cost more if a refill is more than 45 days late. | Not recorded yet Lilly's savings-card terms are entered by hand; not yet. Your plan's copay applies. | Medicare GLP-1 Bridge, if you meet the rules on Medicare.gov; extended through December 31, 2027. | |
| Mounjaro Single-dose pen · Eli Lilly | $499 / fill*6 | Not recorded yet Lilly's savings-card terms are entered by hand; not yet. Your plan's copay applies. | Not on the Bridge list2 Not one of the GLP-1 Bridge drugs. Check your own Part D plan. | |
| Foundayo Tablet · Eli Lilly | $149–$299 / month7 Some strengths cost more if a refill is more than 45 days late. | Not recorded yet Lilly's savings-card terms are entered by hand; not yet. Your plan's copay applies. | Medicare GLP-1 Bridge, if you meet the rules on Medicare.gov; extended through December 31, 2027. | |
| Wegovy Prefilled pen (injection) · Novo Nordisk | $349–$399 / month8 New patients: $199 for the first 2 fills of the lowest strengths, through 2026-12-31. | Novo Nordisk savings offer: up to $100 a month off your copay; commercial (non-government) insurance only. | Medicare GLP-1 Bridge, if you meet the rules on Medicare.gov; extended through December 31, 2027. From January 1, 2027, Medicare's negotiated price for semaglutide is $274 for a 30-day supply (the price pharmacies get for Part D, not what you pay). | |
| Wegovy Tablet · Novo Nordisk | $149–$299 / month13 | Novo Nordisk savings offer: up to $100 a month off your copay; commercial (non-government) insurance only. | Medicare GLP-1 Bridge, if you meet the rules on Medicare.gov; extended through December 31, 2027. From January 1, 2027, Medicare's negotiated price for semaglutide is $274 for a 30-day supply (the price pharmacies get for Part D, not what you pay). | |
| Ozempic Prefilled pen (injection) · Novo Nordisk | $349–$499 / month14 New self-pay patients: $199 for the first 2 fills of the lowest strengths, through 2026-12-31. | Novo Nordisk savings offer: up to $100 a month off your copay; commercial (non-government) insurance only. | Not one of the GLP-1 Bridge drugs. Check your own Part D plan. From January 1, 2027, Medicare's negotiated price for semaglutide is $274 for a 30-day supply (the price pharmacies get for Part D, not what you pay). | |
| Ozempic Tablet · Novo Nordisk | $149–$299 / month15 | Novo Nordisk savings offer: up to $100 a month off your copay; commercial (non-government) insurance only. | Not one of the GLP-1 Bridge drugs. Check your own Part D plan. From January 1, 2027, Medicare's negotiated price for semaglutide is $274 for a 30-day supply (the price pharmacies get for Part D, not what you pay). |
Medicaid: Of 33 states checked against their own documents, 5 have a prior-authorization path for weight management, 1 covers it with added limits, 21 do not cover weight loss alone, and 6 list criteria only for other uses. See your state.
*Eli Lilly's listings show a quantity of 1 without the days covered, so they are a price per fill, not confirmed as per month.
Download this table (CSV) · Work out your own monthly cost · Price change log
Other drugs
Drugs outside the GLP-1 group have different official prices: the maker's list price, Medicare's negotiated price, Medicare's Part B payment limit for drugs given in a clinic, and the average price pharmacies pay (NADAC). Part D's yearly out-of-pocket limit is $2,400 in 2027.45
| Drug | Maker's list price | Medicare negotiated price | Medicare Part B limit | Pharmacy acquisition cost (NADAC) |
|---|---|---|---|---|
| Eliquis Bristol Myers Squibb and Pfizer | $34616 Per 30-day supply (60 tablets) | $231 / 30 days17 From Jan 1, 2026 | Not listed | $5.51–$5.52 / tablet18 Oct 21, 2026 |
| Jardiance Boehringer Ingelheim | Not published | $197 / 30 days19 From Jan 1, 2026 | Not listed | $11.19 / tablet20 Oct 21, 2026 |
| Dupixent Sanofi and Regeneron | $4,193.0321 Per carton (2 injections, which the maker defines as a monthly supply) | None | Not listed | $2,017.88–$2,026.53 / pen or syringe22 Oct 21, 2026 |
| Tremfya Johnson & Johnson | $14,566.4423 Per single SC injection or IV infusion | None | $14,620.07–$14,734.21 / pen or syringe25 Oct 21, 2026 | |
| Skyrizi AbbVie | Not published | None | $22,795.09–$23,052.15 / pen or syringe27 Oct 21, 2026 | |
| Rinvoq AbbVie | Not published | None | Not listed | $229.37–$459.84 / tablet28 Oct 21, 2026 |
| Keytruda Merck | $12,517.4429 Per dose given every 3 weeks ($25,034.88 for a dose given every 6 weeks) | None | Not listed | |
| Biktarvy Gilead | Not published | None | Not listed | $136.63–$136.75 / tablet31 Oct 21, 2026 |
| Otezla Amgen | $5,589.8932 Per 60 tablets of 30 mg | $1,650 / 30 days33 From Jan 1, 2027 | Not listed | $89.95–$181.20 / tablet34 Oct 21, 2026 |
| Humira AbbVie | Not published | None | Not listed | $3,366.95–$6,735.20 / pen or syringe35 Oct 21, 2026 |
| Journavx Vertex Pharmaceuticals | $15.5036 Per 50 mg pill | None | Not listed | $15.41 / tablet37 Jul 1, 2026 |
| Yeztugo Gilead | Not published | None | Not listed | |
| Kisunla Eli Lilly | $731.4939 Per 350 mg/20 mL vial | None | Not listed | |
| Leqembi Eisai and Biogen | $274.5541 Per 200 mg/2 mL vial ($686.40 for a 500 mg/5 mL vial) | None | Not listed | |
| Cobenfy Bristol Myers Squibb | $1,88743 Per 30-day supply | None | Not listed | $30.12–$30.25 / capsule44 Oct 21, 2026 |
What is and isn't included
- Self-pay prices are the makers' own listings on TrumpRx.gov, checked weekly; Novo Nordisk's are cross-checked against NovoCare's price page.
- With commercial insurance, what you pay depends on your plan. The savings offer lowers your copay within its listed limits; it does not set a price on its own.
- Retail-pharmacy coupon-card prices are not included. We do not collect prices from coupon or discount-card sites.
- Eli Lilly's own savings-card terms are entered by hand from Lilly's pages; until they are entered, that cell says so.
- When any of these change, the change is checked against the official page and logged on the price change log.
Cite this data
Free to reuse under CC BY 4.0: please credit MedCost Clear and link to this page. Every figure keeps its official source and date.
Which drug, which dose, and whether to start, stop or switch are medical decisions. Ask your doctor or pharmacist.
Get an email when a price or rule changes
Only when an official GLP-1 self-pay price or a Medicare or Medicaid rule changes, at most once a week, with the official source for every change.
Official sources for this page (45)
“*Eligibility required, terms and conditions apply. Review full terms and conditions.”
TrumpRx.gov: Zepbound Single-dose vial listing · as of Oct 17, 2026“Starting July 1, 2026, Medicare covers these GLP-1 drugs: Foundayo® (tablet) Wegovy® (injection or tablet) Zepbound® (KwikPen® only. The program doesn’t cover single-dose Zepbound® vials or pens).”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“*Eligibility required, terms and conditions apply. Review full terms and conditions.”
TrumpRx.gov: Zepbound KwikPen (multi-dose) listing · as of Oct 17, 2026“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
Medicare.gov: Weight loss drugs · as of Nov 5, 2026“The Centers for Medicare & Medicaid Services (CMS) is extending the Medicare GLP-1 Bridge through December 31, 2027.”
CMS HPMS memo, April 21, 2026 · as of Oct 17, 2026“*Eligibility required, terms and conditions apply. Review full terms and conditions.”
TrumpRx.gov: Mounjaro Single-dose pen listing · as of Oct 17, 2026“The price for the 2.5mg dose is temporarily reduced through December 31, 2026. Regular price is $199. The price for the 5.5mg dose is temporarily reduced through December 31, 2026. Regular price is $299. *Eligibility required, terms and conditions apply. Review full terms and conditions.”
TrumpRx.gov: Foundayo Tablet listing · as of Oct 17, 2026“Limited Time Offer – New patients pay $199* for the first two monthly fills of Wegovy® (semaglutide) injection 0.25mg and 0.5mg, then $349/month. Only available for 2 monthly fills between 11/17/2025- 12/31/2026. For each fill after, pay $349/month for Wegovy® 0.25mg, 0.5mg, 1mg, 1.7mg, or 2.4mg and $399/month for Wegovy® HD 7.2mg.”
TrumpRx.gov: Wegovy Prefilled pen (injection) listing · as of Oct 17, 2026“Pay as little as $25, subject to a maximum savings of $100/month. Government beneficiaries excluded.”
NovoCare Pharmacy · as of Nov 9, 2026“Pay as little as $25 per month”
NovoCare Pharmacy · as of Nov 9, 2026“Ozempic; Rybelsus; Wegovy Novo Nordisk Inc. Type 2 diabetes; Type 2 diabetes and cardiovascular disease; Cardiovascular disease and obesity/ overweight $274 $959 71%”
“A participating drug company with a selected drug is required to ensure the negotiated price is made available to eligible individuals and to the pharmacies, mail-order services, and other entities that dispense the selected drug with respect to such individuals.”
“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month is defined as one bottle containing 30 tablets. Novo Nordisk reserves the right to modify or cancel this offer at any time. See full Terms and Conditions.”
TrumpRx.gov: Wegovy Tablet listing · as of Oct 17, 2026“Limited Time Offer – New self-pay patients pay $199* for the first two monthly fills of Ozempic® (semaglutide) injection 0.25mg or 0.5mg. Only available for 2 monthly fills between 11/17/2025 – 12/31/2026. For each fill after, pay $349/month for Ozempic® 0.25mg, 0.5mg or 1mg, and $499/month for Ozempic® 2mg. For eligible patients only.”
TrumpRx.gov: Ozempic Prefilled pen (injection) listing · as of Oct 17, 2026“Self-pay pricing varies by dose. Eligibility and restrictions apply. Government beneficiaries excluded. One month defined as 1 bottle of 30 tablets. Novo Nordisk reserves the right to modify or cancel at any time. See full terms and conditions.”
TrumpRx.gov: Ozempic Tablet listing · as of Oct 17, 2026“The list price for a 30-day supply of ELIQUIS is $346 ... As of January 2026 for ELIQUIS 60 tablet count. List price is also known as wholesale acquisition cost or WAC.”
Bristol Myers Squibb: Eliquis pricing (entered by hand) · as of Oct 22, 2026“Eliquis Bristol Myers Squibb Prevention and treatment of blood clots $231.00 $521.00 56% $18,275,108,000 3,928,000”
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
“Jardiance Boehringer Ingelheim Diabetes; Heart failure; Chronic kidney disease $197.00 $573.00 66% $8,840,947,000 1,883,000”
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
“The list price of DUPIXENT is $4,193.03 USD per carton ... List price is also referred to as wholesale acquisition cost or WAC ... A monthly supply/carton of DUPIXENT (300 mg or 200 mg) is defined as 2 injections per month. List price as of 1/2/2026.”
Sanofi: Dupixent pricing (entered by hand) · as of Oct 22, 2026- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
“As of March 2025, the list price of TREMFYA® is $14,566.44 per single SC injection or IV infusion.”
Johnson & Johnson: Tremfya pricing (entered by hand) · as of Oct 22, 2026- CMS: Medicare Part B Payment Limit File (quarterly ASP pricing) · as of Oct 23, 2026
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
- CMS: Medicare Part B Payment Limit File (quarterly ASP pricing) · as of Oct 23, 2026
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
“The list price for each indicated dose of KEYTRUDA when given every 3 weeks is $12,517.44. The list price for each indicated dose of KEYTRUDA when given every 6 weeks is $25,034.88. The list price is current as of September 2026.”
Merck: Keytruda pricing (entered by hand) · as of Oct 22, 2026- CMS: Medicare Part B Payment Limit File (quarterly ASP pricing) · as of Oct 23, 2026
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
- TrumpRx.gov: Otezla listing · as of Oct 23, 2026
“Otezla; Otezla XR Amgen Inc. Oral ulcers in Behçet’s Disease; Plaque psoriasis; Psoriatic arthritis $1,650 $4,722 65% $1,045,443,000 31,000”
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 23, 2026
“Vertex has established a wholesale acquisition cost for JOURNAVX in the United States of $15.50 per 50mg pill.”
Vertex Pharmaceuticals: Journavx pricing (entered by hand) · as of Oct 25, 2026- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 28, 2026
- CMS: Medicare Part B Payment Limit File (quarterly ASP pricing) · as of Oct 23, 2026
“The list price of Kisunla is $731.49 per 350 mg/20 mL vial ... List price, also referred to as wholesale acquisition cost or WAC, is the price at which Lilly sells its products to wholesalers. ... WAC from AnalySource accessed on October 1, 2026.”
Eli Lilly: Kisunla pricing (entered by hand) · as of Oct 25, 2026- CMS: Medicare Part B Payment Limit File (quarterly ASP pricing) · as of Oct 23, 2026
“Eisai Inc Price List, Effective October 5, 2026: Leqembi 200mg/2ml (100mg/mL) 1 Vial $274.55; Leqembi 500mg/5ml (100mg/mL) 1 Vial $686.40; Leqembi 360 mg/1.8 mL (200 mg/mL) 1 single-dose prefilled autoinjector $385.00; LEQEMBI 250 mg/1.25 mL (200 mg/mL) 2 single-dose prefilled autoinjectors $770.00”
Eisai: Leqembi pricing (entered by hand) · as of Oct 25, 2026- CMS: Medicare Part B Payment Limit File (quarterly ASP pricing) · as of Oct 23, 2026
“The Wholesale Acquisition Cost (WAC), also known as list price, is $1,887 for 30 days of COBENFY. However, the WAC may not reflect the price paid by customers.”
Bristol Myers Squibb: Cobenfy pricing (entered by hand) · as of Oct 25, 2026- data.medicaid.gov: NADAC (National Average Drug Acquisition Cost) 2026 · as of Oct 25, 2026
“Out-of-Pocket Threshold: $2,100 Out-of-Pocket Threshold: $2,400”
CMS: CY 2027 Medicare Advantage and Part D Rate Announcement (Table V-6) · as of Oct 23, 2026